| Year |
Citation |
Score |
| 2019 |
Heinlen L, Chakravarty EF. Lupus Nephritis: Duration of Therapy and Possibility of Withdrawal. Advances in Chronic Kidney Disease. 26: 387-392. PMID 31733723 DOI: 10.1053/J.Ackd.2019.08.010 |
0.322 |
|
| 2019 |
Jog NR, McClain MT, Heinlen LD, Gross T, Towner R, Guthridge JM, Axtell RC, Pardo G, Harley JB, James JA. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. Journal of Autoimmunity. 102332. PMID 31515129 DOI: 10.1016/J.Jaut.2019.102332 |
0.669 |
|
| 2013 |
Lanis JM, Heinlen LD, James JA, Ballard JD. Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. Plos Pathogens. 9: e1003523. PMID 23935501 DOI: 10.1371/Journal.Ppat.1003523 |
0.449 |
|
| 2010 |
Heinlen LD, Ritterhouse LL, McClain MT, Keith MP, Neas BR, Harley JB, James JA. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. Journal of Molecular Medicine (Berlin, Germany). 88: 719-27. PMID 20396862 DOI: 10.1007/S00109-010-0618-1 |
0.729 |
|
| 2010 |
Heinlen LD, McClain MT, Ritterhouse LL, Bruner BF, Edgerton CC, Keith MP, James JA, Harley JB. 60 kD Ro and nRNP A frequently initiate human lupus autoimmunity. Plos One. 5: e9599. PMID 20224770 DOI: 10.1371/Journal.Pone.0009599 |
0.641 |
|
| 2009 |
Cole L, Heinlen L, Harley J, James J. S.18. Ribosomal P Autoantibodies are Commonly Present Before SLE Onset and are Directed Against Non-C Terminal Portions of the Protein Clinical Immunology. 131: S138. DOI: 10.1016/J.Clim.2009.03.405 |
0.485 |
|
| 2007 |
Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, James JA. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis and Rheumatism. 56: 2344-51. PMID 17599763 DOI: 10.1002/Art.22665 |
0.677 |
|
| 2007 |
Berggren MA, Heinlen L, Isaksson A, Nyström U, Ricksten A. EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndrome. Journal of Medical Virology. 79: 963-9. PMID 17516536 DOI: 10.1002/Jmv.20893 |
0.301 |
|
| 2007 |
Heinlen L, McClain M, Prestigiacomo T, Bruner B, Binder S, Edgerton C, Rubertone M, James J, Harley J. Autoantibody Onset Prior to SLE Diagnosis Follows Predictable Patterns of Development Clinical Immunology. 123: S101. DOI: 10.1016/J.Clim.2007.03.467 |
0.648 |
|
| 2006 |
Heinlen L, McClain M, Pachner A, Harley J, James J. Sa.16. Multiple Sclerosis Patients Exhibit a Unique Humoral Response to the Epstein-Barr Virus Nuclear Antigen-1 Clinical Immunology. 119: S110. DOI: 10.1016/J.Clim.2006.04.248 |
0.664 |
|
| 2006 |
Heinlen L, McClain M, Miner J, Scofield H, Harley J, James J. F.66. SLE Patient Anti-Ro 169 Antibodies Are Associated with Leucopenia and Bind the Surface of Neutrophils Clinical Immunology. 119: S74. DOI: 10.1016/J.Clim.2006.04.106 |
0.69 |
|
| 2005 |
McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature Medicine. 11: 85-9. PMID 15619631 DOI: 10.1038/Nm1167 |
0.723 |
|
| 2004 |
McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis and Rheumatism. 50: 1226-32. PMID 15077305 DOI: 10.1002/Art.20120 |
0.714 |
|
| 2003 |
Heinlen LD, McClain MT, Kim X, Quintero DR, James JA, Harley JB, Scofield RH. Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. Lupus. 12: 335-7. PMID 12729062 DOI: 10.1191/0961203303lu377xx |
0.667 |
|
| Show low-probability matches. |